Buy Ranbaxy: Sukhani

Published on Tue, Jan 31, 2012 at 10:27 |  Source : CNBC-TV18

Updated at Tue, Jan 31, 2012 at 16:34  

40092 Investors following Ranbaxy Labs. Share this News with them.
0
0
Share on Tumblr
Sudarshan Sukhani, s2analytics

Excerpts from Bazaar on CNBC-TV18 Watch the full show ยป

ALSO READ

Sudarshan Sukhani of s2analytics is of the view that one can buy Ranbaxy for day trading.

Sukhani told CNBC-TV18, "Because Rural Electrification Corporation (REC) is in an uptrend I am assuming that yesterday's knock was just a one-off event and therefore the stock - I am assuming it will open its lows on close by, that should be bought into and keep a tight stop loss."

He further added, "Ranbaxy is a day trading buy; some minor signs of life are there. There is a trade on the long side but I wouldn't take any long side positions in Ranbaxy, it's not a positional trade. For somebody who wants to trade for a day or two days consider going long in it."

Disclosure: I have no personal holding in the above stocks.

  

Trending News

Business News

Hands on Preview of the Samsung Galaxy S III
Morgan Stanley bomb: Predicts India's 2012 GDP at 5.7% "Morgan Stanley bomb: Predicts India's 2012 GDP at 5.7%"

Ranvir Sena chief killed, Bihar on high alert

TCI Fund Says Arbitration Over CIL Likely Unless Govt More Flexible

The latest earning numbers FIRST on CNBC-TV18
Videos

Jun 1 2012, 14:57

Delisting candidates are risky; be cautious: SMC

- in MARKET OUTLOOK

Jun 1 2012, 11:57

Raamdeo Agrawal lauds Q4 nos, sees drastic rate cuts ahead

- in MARKET OUTLOOK

Interviews

Jun 1 2012, 15:36 | Source: CNBC-TV18

M&M performed well on strategy, not fuel prices: Nayer  

Jun 1 2012, 11:29 | Source: CNBC-TV18

HDIL eyes revenues of Rs 2500 cr in FY13  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!